Sfoglia per AUTORE
MUSTO P
Collezione AOU Alessandria

  

Items : 13

Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023-2024: EPICOVIDEHA-EPIFLUEHA Report. in American journal of hematology / Am J Hematol. 2025 Mar;100(3):358-374. doi: 10.1002/ajh.27565. Epub 2024 Dec 23.
2025
AOU Alessandria
AOU Città della Salute di Torino

D?browska-Iwanicka A; Brunetti SC; Drozd-Soko?owska J; van den Ven L; Fianchi L; Limongelli A; Sciumè M; Leotta D; Bavastro M; Musto P; Delia M; Wolf D; Anastasopoulou AN; Mayer J; Víšek B; Varricchio G; Arellano E; Córdoba R; Cerchione C; Prin R; Cvetanoski M; Mitrovi? M; Aiello TF; Glenthøj A; Gräfe SK; Schönlein M; Hersby DS; Adži?-Vuki?evi? T; Coppola N; et alii...

End of induction [(18)F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trial. in European journal of nuclear medicine and molecular imaging / Eur J Nucl Med Mol Imaging. 2024 Sep;51(11):3311-3321. doi: 10.1007/s00259-024-06765-z. Epub 2024 Ma
2024
AOU Alessandria
AO Cuneo

Usai SV; Vitolo U; Falcinelli F; Gini G; Galimberti S; Roti G; Mannina D; Musto P; Conconi A; Massaia M; Bari A; Califano C; Arcari A; Chiarenza A; Pavone V; Bolis SAM; Bianchi B; Tosi P; Musuraca G; Ladetto M; Barbieri E; Monaco L; Franceschetto A; Peano S; Durmo R; Marcheselli L; Bergesio F; Fallanca F; Chauvie S; et alii...

2024
AOU Alessandria
AOU Città della Salute di Torino

Bruno B; Zamagni E; Stefanoni P; Palmieri S; Liberati AM; Monaco F; Annibali O; Galieni P; Garzia M; Olivero M; Rogers J; Ruggeri M; Pescosta N; Pisani F; Tosi P; Pascarella A; Pietrantuono G; Arigoni M; De Sabbata G; Bertamini L; Belotti A; Rota-Scalabrini D; D'Agostino M; Calogero RA; Boccadoro M; Musto P; Gay F;

Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry. in Hematological oncology / Hematol Oncol. 2024 Jan;42(1):e3240. doi: 10.1002/hon.3240. Epub 2023 Dec 4.
2024
AOU Alessandria
AOU San Luigi di Orbassano

Rahimli L; Marchesi F; Limongelli A; Bavastro M; Rá?il Z; Hanakova M; Aiello TF; Nunes-Rodrigues R; Emarah Z; Arellano E; Quattrone M; Ilhan O; García-Sanz R; Mayer J; Žák P; Ammatuna E; Cordoba R; Zambrotta GPM; Izuzquiza M; Cabirta A; Nordlander A; Obr A; Çolak GM; Szotkowski T; Wolf D; De-Ramón C; Del Principe MI; Marques-De-Almeida J; Dargenio M; et alii...

Real-world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts. in American journal of hematology / Am J Hematol. 2023 Aug;98(8):E204-E208. doi: 10.1002/ajh.26960. Epub 2023 May 24.
2023
AOU Alessandria
ASL Città di Torino
ASL Torino 4
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara

Della Porta MG; Santini V; Naldi I; Finelli C; Sancetta R; Selleri C; Pasini P; Giordano L; Turrini M; Tosi P; Tanasi I; Frigeni M; Grimaldi D; Marchetti M; Norata M; Galimberti S; Fianchi L; Di Veroli A; Ferrara F; Di Bona E; Bono R; Castelli A; Calvisi A; Rivoli G; Molteni A; Nicolino B; Occhini U; Leuzzi L; Genua A; et alii...

High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2022 Sep 20;40(27):3120-3131. doi: 10.1200/JCO.21.01393. Epub 2022 Jun 6.
2022
AOU Alessandria
AOU Città della Salute di Torino

Musto P; Boccadoro M; Gay F; Belotti A; Tacchetti P; Fazio F; Zambello R; Luppi M; Liberati AM; Palmieri S; Annibali O; Monaco F; Galieni P; Pisani F; Capra A; Gilestro M; Curci P; Pascarella A; Tosi P; De Sabbata G; Pietrantuono G; Gentile M; Ledda A; Paris L; Morè S; Corradini P; Rota-Scalabrini D; Oliva S; Bertamini L; et alii...

A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study. in Blood advances / Blood Adv. 2022 Jan 11;6(1):327-338. doi: 10.1182/bloodadvances.2021005691.
2022
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino
AOU Novara

Corradini P; Merli F; Passamonti F; Candoni A; Krampera M; Venditti A; Selleri C; Tosi P; Lanza F; Conconi A; La Barbera EO; Gambacorti-Passerini C; Visani G; Vallisa D; Rigacci L; Armiento D; Gherlinzoni F; Tafuri A; Galimberti S; Bocchia M; Corso A; Cilloni D; Cardinali V; Turrini M; Trentin L; Cuneo A; Della Porta M; Massaia M; Fracchiolla N; et alii...

2022
AOU Alessandria
AOU Novara

Inzoli A; Cantore N; Ferreri AJM; Cerqueti M; Santini S; Turrini M; Arcaini L; Caparrotti G; Battistini R; Murineddu M; Camera A; Marino D; Musto P; Stelitano C; Corradini P; Ferrando P; Mannina D; Guarini A; Fraticelli V; Ladetto M; Liberati AM; Santoro A; Consoli U; Mengarelli A; Gaidano G; Petrini M; Cardinale G; Ronci B; La Nasa G; et alii...

COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies. in British journal of haematology / Br J Haematol. 2021 Nov;195(3):371-377. doi: 10.1111/bjh.17704. Epub 2021 Jul 16.
2021
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino
AOU Novara

Corradini P; Pagano L; Grossi PA; Bertù L; Zaja F; Musto P; Petrucci L; Lanza F; Visani G; Mina R; La Barbera EO; Cattaneo C; Candoni A; Krampera M; Luppi M; Cardinali V; Galimberti S; Armiento D; Bocchia M; Marchesi F; Fracchiolla N; Tafuri A; Pinto A; Arcaini L; Massaia M; Ladetto M; Busca A; Venditti A; Farina F; et alii...

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study. in The Lancet. Haematology / Lancet Haematol. 2020 Oct;7(10):e737-e745. doi: 10.1016/S2352-3026(20)30251-9. Epub 2020 Aug 13.
2020
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino
AOU Novara

Corradini P; Pagano L; Bertù L; Corrao G; Grossi PA; Franchi M; Oberti M; Zappasodi P; Visco C; Armiento D; Pane F; Pinto A; Galieni P; Rigacci L; Candoni A; Venditti A; Fava C; Federici AB; Marchesi F; Musto P; Gentile M; Bocchia M; Di Renzo N; Olivieri A; Ferrandina C; Selleri C; Ortu La Barbera E; Luppi M; Scattolin AM; et alii...

2020
ASL Asti
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino

Larocca A; Romano A; Sonneveld P; Ria R; Musto P; Liberati AM; Offidani M; Giuliani N; Marchetti M; Mosca-Siez ML; de Fabritiis P; Gobbi M; Ballanti S; Cellini C; Grasso M; Monaco F; Ronconi S; Pescosta N; Di Lullo G; Capra A; Belotti A; Petrucci MT; Boccadoro M; Zambello R; Mina R;

Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice. in Haematologica / Haematologica. 2019 Aug;104(8):1589-1596. doi: 10.3324/haematol.2018.205054. Epub 2019 Feb 28.
2019
AOU Alessandria
AOU Città della Salute di Torino

Saglio G; Ferrero D; Baccarani M; Pane F; Specchia G; Lunghi F; Sorà F; Iuliano F; Caocci G; Russo S; Musto P; Luciano L; Sgherza N; Giai V; Cavazzini F; Stagno F; Levato L; Annunziata M; Santoro M; Cedrone M; Breccia M; Latagliata R; Cattaneo D; Iurlo A; Bocchia M; Galimberti S; Rapezzi D; Crugnola M; Bergamaschi M; et alii...

Predicting failure of hematopoietic stem cell mobilization before it starts: the predicted poor mobilizer (pPM) score. in Bone marrow transplantation / Bone Marrow Transplant. 2018 Apr;53(4):461-473. doi: 10.1038/s41409-017-0051-y. Epub 2018 Jan 12.
2018
AOU Alessandria

Olivieri J; Attolico I; Nuccorini R; Pascale SP; Chiarucci M; Poiani M; Corradini P; Farina L; Gaidano G; Nassi L; Sica S; Piccirillo N; Pioltelli PE; Martino M; Moscato T; Pini M; Zallio F; Ciceri F; Marktel S; Mengarelli A; Musto P; Capria S; Merli F; Codeluppi K; Mele G; Lanza F; Specchia G; Pastore D; Milone G; et alii...